Publicaciones (59) Publicaciones en las que ha participado algún/a investigador/a

2015

  1. 37th Annual San Antonio Breast Cancer Symposium. Summary of the most important translational and clinical contributions

    Revista de Senologia y Patologia Mamaria

  2. A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer

    Gynecologic Oncology, Vol. 136, Núm. 1, pp. 130-135

  3. Adjuvant chemoradiation in pancreatic cancer: A pooled analysis in elderly (≥75 years) patients

    Anticancer Research, Vol. 35, Núm. 6, pp. 3441-3446

  4. Adjuvant chemotherapy in rectal cancer: Defining subgroups who may benefit after neoadjuvant chemoradiation and resection: A pooled analysis of 3,313 patients

    International Journal of Cancer, Vol. 137, Núm. 1, pp. 212-220

  5. Agonists of Co-stimulation in Cancer Immunorapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOS

    Seminars in Oncology, Vol. 42, Núm. 4, pp. 640-655

  6. Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer

    Cancer Cytopathology, Vol. 123, Núm. 4, pp. 230-236

  7. BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors

    Melanoma Research, Vol. 25, Núm. 6, pp. 486-495

  8. Chemotherapy beyond the second line of treatment in non-small cell lung cancer: New drug development

    Fighting Lung Cancer with Conventional Therapies (Nova Science Publishers, Inc.), pp. 229-240

  9. Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

    BMC Genomics, Vol. 16, Núm. 1

  10. Deficit attention hyperactivity disorder: Is its prevalence growing or is its diagnosis been promoted?

    Pediatria de Atencion Primaria

  11. Development of the National Kidney Transplantation Program in Uruguay

    Transplantation Proceedings, Vol. 47, Núm. 8, pp. 2336-2339

  12. ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

    Radiotherapy and Oncology, Vol. 117, Núm. 3, pp. 559-581

  13. Early prediction of disease progression in small cell lung cancer: Toward model-based personalized medicine in oncology

    Cancer Research, Vol. 75, Núm. 12, pp. 2416-2425

  14. Enhancing T cell performance against cancer in combination treatment strategies

    Cancer Drug Discovery and Development (Humana Press Inc.), pp. 245-258

  15. Factors influencing the use of thromboprophylaxis in cancer outpatients in clinical practice: A prospective study

    Thrombosis Research, Vol. 136, Núm. 6, pp. 1145-1148

  16. Frequency and characteristics of familial melanoma in Spain: The FAM-GEM-1 study

    PLoS ONE, Vol. 10, Núm. 4

  17. Functional expression of CD137 (4-1BB) on T helper follicular cells

    OncoImmunology, Vol. 4, Núm. 12

  18. Gastric/GE Junction Cancer

    Clinical Radiation Oncology (Elsevier Inc.), pp. 906-933.e5

  19. Human cytomegalovirus and Epstein-Barr virus infection impact on 18F-FDG PET/CT SUVmax, CT volumetric and KRAS-based parameters of patients with locally advanced rectal cancer treated with neoadjuvant therapy

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 2, pp. 186-196

  20. Immune checkpoint inhibitors: Therapeutic advances in melanoma

    Annals of Translational Medicine, Vol. 3, Núm. 18